Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-011718
Filing Date
2019-08-06
Accepted
2019-08-06 15:33:22
Documents
32
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 266392
2 form10q_001.jpg GRAPHIC 4447
3 ex31-1.htm EX-31.1 17675
4 ex31-2.htm EX-31.2 17887
5 ex32-1.htm EX-32.1 8137
  Complete submission text file 0001493152-19-011718.txt   999167

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE vapa-20190630.xml EX-101.INS 79991
7 XBRL SCHEMA FILE vapa-20190630.xsd EX-101.SCH 13230
8 XBRL CALCULATION FILE vapa-20190630_cal.xml EX-101.CAL 20858
9 XBRL DEFINITION FILE vapa-20190630_def.xml EX-101.DEF 34924
10 XBRL LABEL FILE vapa-20190630_lab.xml EX-101.LAB 96328
11 XBRL PRESENTATION FILE vapa-20190630_pre.xml EX-101.PRE 73702
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
VapAria Corp (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 191001792
SIC: 2834 Pharmaceutical Preparations